What we do
Through PET-CT, nuclear medicine and specialist radiopharmaceutical expertise, Alliance Medical Group supports earlier diagnosis, more accurate staging, targeted treatment planning and response assessment across complex clinical pathways.
Delivered at scale, molecular imaging helps healthcare systems expand precision diagnostics and support more personalised care.
%202%204.avif)
PET-CT scans
delivered each year
research accredited PET-CT scanners across our network
radiopharmacy
production units
cyclotrons across the current platform
Oncology
To support cancer diagnosis, staging, treatment planning and response assessment through detailed insight into tumour biology and disease activity.
Neurology
To provide additional clinical insight where functional and metabolic information can support diagnosis, disease assessment and ongoing management.
Cardiology
To support specialist cardiovascular pathways through assessment of disease activity, myocardial viability and response to treatment.
Research and precision medicine
To support the development and adoption of novel tracers, radiopharmaceuticals and more personalised approaches to diagnosis and treatment.
Molecular imaging depends on reliable access to the right radiopharmaceuticals at the right time. By combining imaging capability with tracer production and supply expertise, Alliance Medical Group supports the infrastructure needed to deliver precision diagnostics consistently and at scale.
This capability connects naturally with diagnostic imaging, radiopharmacy, research & development and data-led insight.
Northern Europe brings together PET-CT services, licensed radiopharmaceutical production and specialist tracer expertise across Germany, the Netherlands, Norway, Austria and Poland.
The region supports advanced imaging pathways through specialist tracers including PSMA, FBB, AV45 and AV1451, with coordinated production and supply designed to provide reliability, continuity and access across multiple healthcare systems.
Delivering diagnostics
and insight at scale
